Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chaihuguizhiganjiang-suanzaoren decoction granules (CSG) is an investigational Traditional Chinese Medicine (TCM) herbal formula developed as a granule formulation. It is a combination of two classical TCM decoctions: the Chaihuguizhiganjiang decoction and the Suanzaoren (Ziziphus spinosa seed) decoction. The formula is specifically designed to treat primary insomnia in patients presenting with the TCM syndrome pattern of 'spleen deficiency and liver heat.' It is currently being evaluated in a multicenter, randomized, double-blind, placebo-controlled clinical trial in China, sponsored by the Beijing Municipal Science & Technology Commission. The treatment aims to harmonize the liver and spleen to improve sleep quality, as assessed by the Pittsburgh Sleep Quality Index (PSQI) over an 8-week treatment period.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chaihuguizhiganjiang-suanzaoren decoction granules.